Researchers have developed an artificial intelligence tool capable of predicting the activity of thousands of genes in tumors using standard biopsy images. This breakthrough technology has the potential to revolutionize cancer treatment by guiding personalized therapies without the need for expensive genomic testing.
The AI analyzes routinely collected biopsy images to identify gene expression patterns associated with cancer, offering insights into tumor behavior and potential vulnerabilities. By bypassing traditional genomic testing, this approach could make precision medicine more accessible and cost-effective for patients worldwide.
This innovation underscores the growing role of AI in healthcare, demonstrating its ability to unlock critical information from existing data, paving the way for more effective and personalized cancer treatments.
